Skip to content

The Acute Effects of Resonant Breathing on Blood Pressure and Heart Rate Variability in Middle-Aged and Older Adults with Primary Hypertension

The Acute Effects of Resonant Breathing on Blood Pressure and Heart Rate Variability in Middle-Aged and Older Adults with Primary Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127946
Enrollment
Unknown
Registered
2026-07-10
Start date
2026-07-13
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary hypertension

Interventions

Group AB:Complete resonance breathing first
Group BA:After completing resonance breathing

Sponsors

China Institute of Sport Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 45 and 79 years old. 2. Meet the diagnostic criteria for essential hypertension specified in the Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 Revised Edition). 3. The antihypertensive treatment regimen has remained relatively stable over the past four weeks. 4. Have normal cognitive function, basic reading and writing abilities, and be proficient in using smartphone applications (APPs). 5. Voluntarily participate in this study and sign the written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary hypertension, hypertensive emergency or hypertensive urgency. 2. Patients with severe dysfunction of vital organs (e.g., NYHA class III or higher heart failure, Child-Pugh class C liver function, end-stage renal disease on dialysis) or active malignant tumor. 3. Patients with severe cerebrovascular or neurological diseases, including but not limited to symptomatic cerebral atherosclerosis, history of stroke, dementia, Parkinson's disease, and intracranial space-occupying lesions. 4. Patients with other severe mental disorders (e.g., major depressive episode, schizophrenia, bipolar affective disorder, obsessive-compulsive disorder [OCD]) or at high suicide risk. 5. Pregnant or lactating women. 6. Any condition that may significantly interfere with study participation or follow-up, such as illiteracy, inability to perform activities of daily living independently, planned relocation out of the study area, or concurrent participation in other interventional clinical studies.

Design outcomes

Primary

MeasureTime frame
Blood pressure;Heart Rate Variability;

Countries

China

Contacts

Public ContactZhang Li

China Institute of Sport Science

zhangli@ciss.cn+86 137 0103 3035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026